SUTRO BIOPHARMA INC's ticker is and the CUSIP is 869367902. A total of 2 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 200 | -93.1% | 0.00% | – |
| Q2 2023 | $13 | – | 2,900 | +1350.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 200 | -92.6% | 0.00% | – |
| Q2 2022 | $14,000 | -30.0% | 2,700 | +92.9% | 0.00% | – |
| Q4 2021 | $20,000 | +185.7% | 1,400 | +250.0% | 0.00% | – |
| Q3 2021 | $7,000 | +133.3% | 400 | +100.0% | 0.00% | – |
| Q2 2021 | $3,000 | -98.3% | 200 | +153.2% | 0.00% | – |
| Q1 2021 | $179,000 | -48.7% | 79 | -50.9% | 0.00% | – |
| Q4 2020 | $349,000 | – | 161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 34,400 | $191,000 | 0.00% |